CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $751,775 | +252.9% | 37,015 | +345.5% | 0.00% | – |
| Q3 2022 | $213,000 | -58.2% | 8,309 | -67.9% | 0.00% | – |
| Q3 2021 | $510,000 | +0.6% | 25,899 | -14.2% | 0.00% | – |
| Q2 2020 | $507,000 | -58.3% | 30,170 | -70.5% | 0.00% | – |
| Q1 2020 | $1,216,000 | -49.7% | 102,209 | -48.8% | 0.00% | -100.0% |
| Q4 2019 | $2,416,000 | +358.4% | 199,628 | +344.3% | 0.00% | – |
| Q1 2019 | $527,000 | -1.7% | 44,926 | +31.7% | 0.00% | – |
| Q2 2018 | $536,000 | -80.7% | 34,125 | -79.8% | 0.00% | -100.0% |
| Q1 2018 | $2,781,000 | -57.1% | 169,050 | -52.9% | 0.00% | 0.0% |
| Q4 2017 | $6,486,000 | -7.5% | 359,145 | -1.2% | 0.00% | -50.0% |
| Q3 2017 | $7,013,000 | +126.9% | 363,363 | +38.7% | 0.00% | +100.0% |
| Q2 2017 | $3,091,000 | +131.4% | 261,933 | +114.8% | 0.00% | – |
| Q1 2017 | $1,336,000 | +161.4% | 121,948 | +73.3% | 0.00% | – |
| Q4 2016 | $511,000 | – | 70,351 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |